Susquehanna International Group, LLP Corvus Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.78 - $5.92 $40,406 - $134,384
22,700 Added 152.35%
37,600 $198,000
Q2 2024

Aug 15, 2024
SELL
$1.36 - $2.29 $136 - $229
-100 Reduced 0.67%
14,900 $27,000
Q1 2024

May 07, 2024
BUY
$1.76 - $2.41 $2,816 - $3,856
1,600 Added 11.94%
15,000 $26,000
Q4 2023

Feb 14, 2024
SELL
$1.08 - $1.92 $3,672 - $6,528
-3,400 Reduced 20.24%
13,400 $23,000
Q3 2023

Nov 14, 2023
BUY
$1.41 - $2.97 $23,688 - $49,896
16,800 New
16,800 $24,000
Q2 2022

Aug 15, 2022
SELL
$0.87 - $2.03 $12,528 - $29,231
-14,400 Reduced 56.47%
11,100 $11,000
Q1 2022

May 16, 2022
SELL
$1.46 - $2.48 $56,648 - $96,224
-38,800 Reduced 60.34%
25,500 $42,000
Q4 2021

Feb 14, 2022
SELL
$2.34 - $5.31 $442,260 - $1 Million
-189,000 Reduced 74.62%
64,300 $155,000
Q3 2021

Nov 15, 2021
BUY
$1.89 - $8.53 $450,198 - $2.03 Million
238,200 Added 1577.48%
253,300 $1.23 Million
Q2 2021

Aug 11, 2021
SELL
$2.46 - $3.14 $117,588 - $150,092
-47,800 Reduced 75.99%
15,100 $40,000
Q4 2020

Feb 16, 2021
BUY
$3.56 - $4.86 $50,908 - $69,498
14,300 Added 29.42%
62,900 $224,000
Q3 2020

Nov 16, 2020
BUY
$2.6 - $5.37 $126,360 - $260,982
48,600 New
48,600 $195,000

Others Institutions Holding CRVS

# of Institutions
73
Shares Held
30.4M
Call Options Held
1.06M
Put Options Held
84.3K
View Full List

About Corvus Pharmaceuticals, Inc.

CRVS Quotes by TradingView
  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $242M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email